The antimycotic activity of 5-fluorocytosine
AUTOR(ES)
Holt, R. J.
RESUMO
5-Fluorocytosine (5 FC) showed marked in vitro activity against nearly all the clinical isolates of Candida and Cryptococcus examined; the required minimal inhibitory concentration was usually below 2 μg/ml and the minimal cidal concentration below 10 μg/ml. The drug had limited activity towards Aspergillus species and dermatophytes. Strains of Candida and other fungi with greatly enhanced resistance were fairly readily obtained by successive cultures on increasingly high concentrations of 5-fluorocytosine.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=477679Documentos Relacionados
- Evidence for Conversion of 5-Fluorocytosine to 5-Fluorouracil in Humans: Possible Factor in 5-Fluorocytosine Clinical Toxicity
- Combined activity of ketoconazole and 5-fluorocytosine on potentially pathogenic yeasts.
- In Vitro Activity of 5-Fluorocytosine Against Candida and Torulopsis Species
- In Vitro And In Vivo Activity of 5-Fluorocytosine on Acanthamoeba
- Pharmacological Studies with 5-Fluorocytosine